Related Experiment Video
Updated: Dec 6, 2025
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD)
Anna B Chociej1, Natalia Wasilewska1, Marta Flisiak-Jackiewicz1
1Department of Pediatrics, Gastroenterology, Hepatology, Nutrition and Allergology, Medical University of Białystok, Bialystok, Poland.
Insights
Nonalcoholic fatty liver disease (NAFLD) is rising in children globally due to obesity. This condition, linked to metabolic syndrome, is increasingly associated with heart problems in pediatric patients.
Area of Science:
- Pediatric Hepatology
- Cardiovascular Health
- Metabolic Disorders
Background:
- Nonalcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in children.
- The global obesity epidemic is driving an increase in NAFLD prevalence worldwide.
- NAFLD is recognized as a hepatic manifestation of metabolic syndrome and a multisystem disorder.
Purpose of the Study:
- To review the current understanding of the relationship between NAFLD and cardiac dysfunction in children.
- To highlight NAFLD as a potential independent risk factor for cardiovascular disease in pediatric populations.
Main Methods:
- Literature review of existing scientific evidence.
- Synthesis of data on NAFLD and associated cardiac abnormalities in children.
Main Results:
- Growing evidence links NAFLD in children to cardiac dysfunction.
- NAFLD is increasingly implicated as an independent risk factor for cardiovascular disease.
Conclusions:
- The association between NAFLD and cardiac dysfunction in children warrants further investigation.
- Early identification and management of NAFLD in children may be crucial for preventing future cardiovascular complications.
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease in children. With the global obesity epidemic, the prevalence of NAFLD is increasing both in industrialized and developing countries. NAFLD is a multisystem disorder and a hepatic manifestation of the metabolic syndrome. Growing scientific evidence suggests that NAFLD is an independent risk factor for cardiovascular disease. This paper briefly describes the current knowledge concerning the association between NAFLD and cardiac dysfunction in children.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
01:30Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
01:26Atherosclerosis III: Management